EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $69,000 | -88.3% | 1,091 | -82.9% | 0.00% | -90.9% |
| Q1 2021 | $591,000 | +0.2% | 6,364 | -3.3% | 0.02% | -8.3% |
| Q4 2020 | $590,000 | +441.3% | 6,584 | +524.1% | 0.02% | +380.0% |
| Q3 2020 | $109,000 | +505.6% | 1,055 | +245.9% | 0.01% | +400.0% |
| Q1 2020 | $18,000 | +200.0% | 305 | +190.5% | 0.00% | – |
| Q4 2019 | $6,000 | +20.0% | 105 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | 0.0% | 105 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -44.4% | 105 | -26.6% | 0.00% | -100.0% |
| Q4 2018 | $9,000 | +800.0% | 143 | +652.6% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 19 | -62.0% | 0.00% | – |
| Q3 2016 | $2,000 | -33.3% | 50 | -50.0% | 0.00% | -100.0% |
| Q2 2016 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |